Formosa Laboratories Balance Sheet

Financials in millions TWD. Fiscal year is January - December.

Millions TWD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	863.13	1,141	1,365	1,526	1,279	729.54
Short-Term Investments	1,113	1,203	1,220	831.41	153.55	-
Trading Asset Securities	93.51	150.42	118.85	153.07	197.52	363.95
Cash & Short-Term Investments	2,070	2,494	2,703	2,510	1,631	1,093
Cash Growth	-20.96%	-7.74%	7.68%	53.97%	49.11%	38.11%
Accounts Receivable	899.69	1,092	1,196	960.01	812.48	773.77
Other Receivables	53.03	77.59	62.44	64.44	14.65	29.42
Receivables	952.72	1,169	1,258	1,024	827.13	803.19
Inventory	2,023	1,716	1,712	1,597	1,602	1,639
Prepaid Expenses	311.28	168.5	192.09	109.24	89.49	79.81
Other Current Assets	3.31	1.64	2.52	2.02	2.24	3.81
Total Current Assets	5,360	5,549	5,868	5,244	4,151	3,619
Property, Plant & Equipment	6,712	6,226	6,204	6,068	5,919	5,901
Long-Term Investments	1,086	1,286	1,481	1,950	2,254	2,083
Goodwill	-	60.4	60.4	30.54	30.54	30.54
Other Intangible Assets	356.69	292.71	154.64	173.89	192.39	217.06
Long-Term Deferred Tax Assets	130.82	116.58	93.04	85.15	97.19	72.3
Other Long-Term Assets	262.46	303.26	33.46	85.42	106.5	93.43
Total Assets	13,908	13,833	13,895	13,636	12,751	12,017
Accounts Payable	371.64	282.38	218.94	203.13	187.49	204.05
Accrued Expenses	4.7	619.81	606.01	474.37	466.82	398.37
Short-Term Debt	683	1,113	732.98	1,534	1,500	1,177
Current Portion of Long-Term Debt	484.78	440.34	388.15	448.78	619.02	284.86
Current Portion of Leases	27.16	23.76	26.07	23.36	22.09	27.74
Current Income Taxes Payable	82.99	30.94	69.45	98.7	141.37	22.89
Current Unearned Revenue	107.95	125.92	62.19	174.88	55.78	109.69
Other Current Liabilities	1,116	264.18	252.02	284.22	149.5	160.87
Total Current Liabilities	2,878	2,900	2,356	3,241	3,142	2,386
Long-Term Debt	2,414	1,949	2,670	2,038	1,638	1,907
Long-Term Leases	85.14	83.07	82.41	19.39	21.44	23.5
Long-Term Unearned Revenue	32.55	26.08	28.94	18.23	16.99	-
Pension & Post-Retirement Benefits	-	25.83	25.18	23.37	16.85	17.38
Long-Term Deferred Tax Liabilities	8.43	13.46	20.97	24.3	24.63	23.95
Other Long-Term Liabilities	193.58	165.01	65.57	61.41	95.13	57.2
Total Liabilities	5,612	5,163	5,249	5,426	4,954	4,415
Common Stock	1,203	1,203	1,203	1,203	1,203	1,203
Additional Paid-In Capital	2,880	3,570	3,773	3,552	3,514	3,503
Retained Earnings	2,688	3,011	2,726	2,810	2,809	2,640
Comprehensive Income & Other	655.39	-26.34	-18.2	6.17	-5.7	49.26
Total Common Equity	7,426	7,757	7,684	7,571	7,521	7,395
Minority Interest	869.57	912.96	962.7	639.25	275.63	206.94
Shareholders' Equity	8,296	8,670	8,647	8,210	7,796	7,602
Total Liabilities & Equity	13,908	13,833	13,895	13,636	12,751	12,017
Total Debt	3,694	3,610	3,899	4,063	3,800	3,420
Net Cash (Debt)	-1,624	-1,115	-1,196	-1,553	-2,169	-2,327
Net Cash Growth	-	-	-	-	-	-
Net Cash Per Share	-14.24	-9.20	-9.88	-12.89	-17.95	-19.15
Filing Date Shares Outstanding	120.66	120.26	120.26	120.26	120.26	120.26
Total Common Shares Outstanding	120.66	120.26	120.26	120.26	120.26	120.26
Working Capital	2,481	2,649	3,512	2,002	1,009	1,234
Book Value Per Share	61.55	64.51	63.90	62.96	62.54	61.50
Tangible Book Value	7,070	7,404	7,469	7,367	7,298	7,148
Tangible Book Value Per Share	58.59	61.57	62.11	61.26	60.68	59.44
Land	-	655.95	655.95	655.95	655.95	655.95
Buildings	-	2,541	2,452	2,377	1,598	1,575
Machinery	-	5,162	4,890	4,479	4,116	3,939
Construction In Progress	-	2,101	1,994	1,957	2,527	2,294
Leasehold Improvements	-	21.12	21.39	15.7	16.78	16.78